Intellia Therapeutics, Inc. · NASDAQ:NTLA
Contrarius Investment Management Ltd's stake in Intellia Therapeutics, Inc. fell to 0.60% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Contrarius Investment Management Ltd's stake in Intellia Therapeutics, Inc. fell to 0.60%, 714,480 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 0.60%
- Shares
- 714,480
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Contrarius Investment Management Ltd | 0.60% | 714,480 |
| Contrarius Investment Management (Bermuda) Ltd | 0.60% | 714,480 |
Source
Related
- Intellia Therapeutics, Inc.
- Contrarius Investment Management Ltd
- Intellia Therapeutics, Inc. shareholders
- Schedule 13G · Contrarius Investment Management Ltd · Nov 12, 2025
- Form 4 · Dube Michael P · Oct 6, 2026
- Form 4 · Leonard John M · Aug 24, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Dulac Edward J III · Jul 24, 2026
- Form 4 · Dulac Edward J III · Jul 6, 2026